Streetbeat News

Stock Prices

BTCUSD

COMPUSD

ETHUSD

Bitcoin and Ethereum traded lower but remained above key levels. 1inch Network was the top gainer over the past 24 hours, while Compound was the biggest loser. The global crypto market cap fell to $1.2 trillion, a 24-hour decline of 1.1%.

Portfolio Pulse from Lisa Levin

July 17, 2023 | 1:45 pm

VRSK

Verisk Analytics Inc. (NASDAQ:VRSK) has seen its shares rise by 17.69% over the past three months. The company's total debt stands at $2.84 billion, with net debt at $2.61 billion after adjusting for $231.90 million in cash-equivalents. The company's debt-ratio is 0.68, indicating a considerable portion of debt is funded by assets. Debt is an important factor in a company's capital structure and contributes to its growth.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 1:45 pm

KSCP

Capybara Research has released a short report on Knightscope, a security camera and robotics company, predicting a significant decline in its equity due to inevitable extensive dilution. The report highlights Knightscope's consistent lack of profitability, inability to scale, ineffective robotic technology, lack of customer satisfaction, and the threat of delisting from Nasdaq. The company is no longer under the “Baby Shelf” rule and can now fully utilize its $100m shelf to raise capital. The report also criticizes Knightscope's CEO, William Santana Li, for his track record of failed ventures and questionable ethical practices.

Portfolio Pulse from Happy Mohamed

July 17, 2023 | 1:43 pm

HCTI

Shares of Healthcare Triangle (HCTI) were halted on a circuit breaker due to a sharp downside movement. However, the stock is now up by 63.8%.

Portfolio Pulse from Happy Mohamed

July 17, 2023 | 1:41 pm

IMMX

Immix Biopharma, Inc. (NASDAQ:IMMX) has reported positive interim data from its ongoing Phase 1b/2a IMMINENT-01 clinical trial for IMX-110 in combination with BeiGene's anti-PD-1 antibody tislelizumab in patients with relapsed/refractory metastatic colorectal cancer. Tumor shrinkage was observed in 75% of patients and tumor control in 25% of patients. No severe adverse events were observed, allowing for the enrollment of the next higher dose cohort. The colorectal cancer market is estimated to reach approximately $31 billion by 2025.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 1:37 pm

POWI

Northland Capital Markets analyst Gus Richard has downgraded Power Integrations (NASDAQ:POWI) from Outperform to Market Perform and set a price target of $82.

Portfolio Pulse from richadhand@benzinga.com

July 17, 2023 | 1:31 pm

TIXT

Barclays analyst Ramsey El-Assal has downgraded TELUS Intl (NYSE:TIXT) from Overweight to Equal-Weight and lowered the price target from $23 to $15.

Portfolio Pulse from richadhand@benzinga.com

July 17, 2023 | 1:29 pm

MNK

Trading of shares in Mallinckrodt Plc has been halted due to pending news.

Portfolio Pulse from Happy Mohamed

July 17, 2023 | 1:28 pm

PARA

Shares of Paramount Global (NASDAQ:PARA) are trading lower due to the ongoing SAG-AFTRA union strike. The strike could increase production costs and disrupt the production of films and TV shows, potentially impacting Paramount's profitability, cash flow, and ability to generate revenue. The company's shares are down by 1.82% to $15.67.

Portfolio Pulse from Henry Khederian

July 17, 2023 | 1:24 pm

JPM

JPMorgan Chase & Co. reported better-than-expected Q2 results with net revenue of $42.4 billion, up 34.1% YoY, beating the consensus of $38.96 billion. Adjusted EPS was $4.37, surpassing the consensus of $3.99. Following the announcement, Credit Suisse and Oppenheimer increased their price targets on JPMorgan.

Portfolio Pulse from Lisa Levin

July 17, 2023 | 1:21 pm